Egyptian International Pharmaceutical Investments (CAI:PHAR) Inventory-to-Revenue : 1.44 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Egyptian International Pharmaceutical Investments's Average Total Inventories for the quarter that ended in Dec. 2023 was E£2,239 Mil. Egyptian International Pharmaceutical Investments's Revenue for the three months ended in Dec. 2023 was E£1,551 Mil. Egyptian International Pharmaceutical Investments's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.44.

Egyptian International Pharmaceutical Investments's Inventory-to-Revenue for the quarter that ended in Dec. 2023 declined from Sep. 2023 (1.60) to Sep. 2023 (1.44)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Egyptian International Pharmaceutical Investments's Days Inventory for the three months ended in Dec. 2023 was 222.79.

Inventory Turnover measures how fast the company turns over its inventory within a year. Egyptian International Pharmaceutical Investments's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.41.

Egyptian International Pharmaceutical Investments Inventory-to-Revenue Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Inventory-to-Revenue Chart

Egyptian International Pharmaceutical Investments Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.53

0.50

0.42

Egyptian International Pharmaceutical Investments Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															1.66	2.22	1.77	1.60	1.44

Competitive Comparison of Egyptian International Pharmaceutical Investments's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Egyptian International Pharmaceutical Investments's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Inventory-to-Revenue falls into.

Egyptian International Pharmaceutical Investments Inventory-to-Revenue Calculation

Egyptian International Pharmaceutical Investments's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (2161.799	+	2242.396)	/	2 )	/	5231.666
=	2202.0975					/	5231.666
=	0.42

Egyptian International Pharmaceutical Investments's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (2235.195	+	2242.396)	/	2 )	/	1550.576
=	2238.7955					/	1550.576
=	1.44

Egyptian International Pharmaceutical Investments (CAI:PHAR) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Egyptian International Pharmaceutical Investments's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	2238.7955	/	916.973	*	365 / 4
	=	222.79

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Egyptian International Pharmaceutical Investments's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	916.973	/	2238.7955
	=	0.41

Egyptian International Pharmaceutical Investments Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.